Home > News > Iranian researchers produced a new nanodrug as contrast-increasing agent for target-imaging of breast cancer
May 8th, 2014
Iranian researchers produced a new nanodrug as contrast-increasing agent for target-imaging of breast cancer
Abstract:
Iranian researchers from Gilan University and Islamic Azad University, Zanjan Branch, produced a new nanodrug as contrast-increasing agent for target-imaging of breast cancer.
Story:
The nanodrug enables early diagnosis of breast cancer tissue and the treatment of the disease.
The nanodrug has high efficiency and it possesses noticeable optical stability in blood. The results showed that the nanodrug is nontoxic on cell cultivation conditions. Results of the research have proved the high potential of the product at animal model level.
According to the results obtained in this research, the produced nanodrug is very powerful in targeting breast cancer cells. The drug is highly absorbed by cancer cells, and the rate of absorption increases as time goes on. It can be concluded from life distribution results that the compound has the power to target breast cancer cells on in vivo conditions, and it can be used as a targeting nanodrug in imaging of breast cancer.
Gold nanorods have very high absorbance, and their sorption spectrum is adjustable at any wavelength inside the infrared domain. On the other hand, radiation of infrared does not harm healthy tissues. When gold nanorods receive the beam inside the tissues, they effectively convert the beam into heat, and miniature explosions begin. Therefore, they act as distinguishing agent in photo-acoustic imaging.
Results of the research have been published in Journal of Photochemistry and Photobiology B: Biology, vol. 130, issue 1, January 2014, pp. 40-46.
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Imaging
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||